These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product]. Norwig J Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487 [TBL] [Abstract][Full Text] [Related]
5. [Microbiologic purity of drugs. Directions and methods for a pharmacopoeia]. Bühlmann X; Gay M; Gubler HU; Hess H; Kabay A; Knüsel F; Sackmann W; Schiller I; Urban S Pharm Acta Helv; 1971 Jun; 46(6):321-50. PubMed ID: 4934777 [No Abstract] [Full Text] [Related]
6. [Sterility test. Remarks on the report on N. Stojtschew, Pharmazie 24, 403 (1969)]. Thonke M Pharmazie; 1970 Feb; 25(2):126. PubMed ID: 5422138 [No Abstract] [Full Text] [Related]
7. The role of the pharmacopoeia in the control of pharmaceutical preparations. Grainger HS Ann Ist Super Sanita; 1975; 11(3-4):305-13. PubMed ID: 1234732 [TBL] [Abstract][Full Text] [Related]
8. [Commentaires on the sterility test of the European Pharmacopoeia (author's transl)]. Dony J J Pharm Belg; 1975; 30(5-6):487-96. PubMed ID: 1214205 [No Abstract] [Full Text] [Related]
9. [Commentaries on the monographs of Group 10 in Volumes I and II of the European Pharmacopoeia]. Bosly J; De Moerloose P J Pharm Belg; 1975; 30(5-6):549-77. PubMed ID: 1214208 [No Abstract] [Full Text] [Related]
11. [Pharmacopoeia--a mirror of the development of pharmaceutical sciences and socialist health service]. Kny L Cesk Farm; 1977 Dec; 26(10):441-5. PubMed ID: 612365 [No Abstract] [Full Text] [Related]
12. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test. Clapp FL Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566 [No Abstract] [Full Text] [Related]
13. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
15. [Chromatographic methods in the European Pharmacopoeia]. Ráfliné RZ; Kószeginé SH; Török I; Paál T Acta Pharm Hung; 2001 Aug; 71(2):205-12. PubMed ID: 11862671 [TBL] [Abstract][Full Text] [Related]
16. [Standards imposed by the pharmacopoeia on drugs]. Büchi J Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534 [No Abstract] [Full Text] [Related]
17. Use of reference substances in pharmacopoeia specifications. Johnson CA Ann Ist Super Sanita; 1975; 11(3-4):314-21. PubMed ID: 1234733 [TBL] [Abstract][Full Text] [Related]
18. [Comments on the monographies of drugs of botanical origin of the European Pharmacopoeia (Volume I and II) (author's transl)]. Lemli J J Pharm Belg; 1975; 30(5-6):443-54. PubMed ID: 2657 [No Abstract] [Full Text] [Related]
19. [On the content of the national part of the Czech pharmacopoeia from the aspect of the formulation of medicinal preparations in pharmacies]. Subert J Ceska Slov Farm; 2008 Jun; 57(3):132-4. PubMed ID: 18683431 [TBL] [Abstract][Full Text] [Related]
20. [ICH4 and pharmacopoeias: similarities and differences]. Artiges A Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]